TGF-β promotes immune responses in the presence of mesenchymal stem cells

Journal of Immunology

Volumn 192, Issue 1, 2014, Pages 103-109

  Xu, Chunliang ^a   Yu, Pengfei ^a   Han, Xiaoyan ^a   Du, Liming ^a   Gan, Jianhe ^b   Wang, Ying ^a   Shi, Yufang ^a,c  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c CHILD HEALTH INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIBODY; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; ENZYME INHIBITION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE;

EID: 84891074677     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302164     Document Type: Article

References (28)

1. Jiang, Y., B.N. Jahagirdar, R. L. Reinhardt, R. E. Schwartz, C. D. Keene, X. R. Ortiz-Gonzalez, M. Reyes, T. Lenvik, T. Lund, M. Blackstad, et al. 2002. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418: 41-49.
2. Ren, G., X. Zhao, Y. Wang, X. Zhang, X. Chen, C. Xu, Z. R. Yuan, A. I. Roberts, L. Zhang, B. Zheng, et al. 2012. CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFa. Cell Stem Cell 11: 812-824.
3. Prockop, D. J., and J. Y. Oh. 2012. Medical therapies with adult stem/progenitor cells (MSCs): a backward journey from dramatic results in vivo to the cellular and molecular explanations. J. Cell. Biochem. 113: 1460-1469.
4. Horwitz, E. M., K. Le Blanc, M. Dominici, I. Mueller, I. Slaper-Cortenbach, F. C. Marini, R. J. Deans, D. S. Krause, and A. Keating; International Society for Cellular Therapy. 2005. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7: 393-395.
5. Muguruma, Y., T. Yahata, H. Miyatake, T. Sato, T. Uno, J. Itoh, S. Kato, M. Ito, T. Hotta, and K. Ando. 2006. Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartment. Blood 107: 1878-1887.
6. Méndez-Ferrer, S., T. V. Michurina, F. Ferraro, A. R. Mazloom, B. D. Macarthur, S. A. Lira, D. T. Scadden, A. Ma'ayan, G. N. Enikolopov, and P. S. Frenette. 2010. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466: 829-834.
7. Prockop, D. J., and J. Y. Oh. 2012. Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol. Ther. 20: 14-20.
8. Sensebé, L., K. Tarte, J. Galipeau, M. Krampera, I. Martin, D. G. Phinney, and Y. Shi; MSC Committee of the International Society for Cellular Therapy. 2012. Limited acquisition of chromosomal aberrations in human adult mesenchymal stromal cells. Cell Stem Cell 10: 9-10, author reply 10-11.
9. Ren, G., X. Chen, F. Dong, W. Li, X. Ren, Y. Zhang, and Y. Shi. 2012. Concise review: mesenchymal stem cells and translational medicine: emerging issues. Stem Cells Transl Med 1: 51-58.
10. Le Blanc, K., F. Frassoni, L. Ball, F. Locatelli, H. Roelofs, I. Lewis, E. Lanino, B. Sundberg, M. E. Bernardo, M. Remberger, et al; Developmental Committee of the European Group for Blood and Marrow Transplantation. 2008. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versushost disease: a phase II study. Lancet 371: 1579-1586.
11. Shi, Y., G. Hu, J. Su, W. Li, Q. Chen, P. Shou, C. Xu, X. Chen, Y. Huang, Z. Zhu, et al. 2010. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res. 20: 510-518.
12. Shi, Y., J. Su, A. I. Roberts, P. Shou, A. B. Rabson, and G. Ren. 2012. How mesenchymal stem cells interact with tissue immune responses. Trends Immunol. 33: 136-143.
13. Uccelli, A., V. Pistoia, and L. Moretta. 2007. Mesenchymal stem cells: a new strategy for immunosuppression? Trends Immunol. 28: 219-226.
14. Ren, G., L. Zhang, X. Zhao, G. Xu, Y. Zhang, A. I. Roberts, R. C. Zhao, and Y. Shi. 2008. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2: 141-150.
15. Ren, G., J. Su, L. Zhang, X. Zhao, W. Ling, A. L'huillie, J. Zhang, Y. Lu, A. I. Roberts, W. Ji, et al. 2009. Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells 27: 1954-1962.
16. Li, M. O., Y. Y. Wan, S. Sanjabi, A. K. Robertson, and R. A. Flavell. 2006. Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol. 24: 99-146.
17. Li, M. O., and R. A. Flavell. 2008. Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity 28: 468-476.
18. Groh, M. E., B. Maitra, E. Szekely, and O. N. Koç. 2005. Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp. Hematol. 33: 928-934.
19. Xu, G., L. Zhang, G. Ren, Z. Yuan, Y. Zhang, R. C. Zhao, and Y. Shi. 2007. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells. Cell Res. 17: 240-248.
20. Gorelik, L., and R. A. Flavell. 2000. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12: 171-181.
21. Xu, C., G. Ren, G. Cao, Q. Chen, P. Shou, C. Zheng, L. Du, X. Han, M. Jiang, Q. Yang, L. Lin, G. Wang, P. Yu, X. Zhang, W. Cao, G. Brewer, Y. Wang, and Y. Shi. 2013. MiR-155 Regulates Immune Modulatory Properties of Mesenchymal Stem Cells by Targeting TAK1-binding Protein 2. J. Biol. Chem. 288: 11074-11079.
22. Derynck, R., and Y. E. Zhang. 2003. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425: 577-584.
23. Datto, M. B., J. P. Frederick, L. Pan, A. J. Borton, Y. Zhuang, and X. F. Wang. 1999. Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction. Mol. Cell. Biol. 19: 2495-2504.
24. Taylor, B. S., M. E. de Vera, R. W. Ganster, Q. Wang, R. A. Shapiro, S. M. Morris, Jr., T. R. Billiar, and D. A. Geller. 1998. Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J. Biol. Chem. 273: 15148-15156.
25. Vodovotz, Y., C. Bogdan, J. Paik, Q. W. Xie, and C. Nathan. 1993. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J. Exp. Med. 178: 605-613.
26. Takaki, H., Y. Minoda, K. Koga, G. Takaesu, A. Yoshimura, and T. Kobayashi. 2006. TGF-beta1 suppresses IFN-gamma-induced NO production in macrophages by suppressing STAT1 activation and accelerating iNOS protein degradation. Genes Cells 11: 871-882.
27. Derynck, R., R. J. Akhurst, and A. Balmain. 2001. TGF-beta signaling in tumor suppression and cancer progression. Nat. Genet. 29: 117-129.
28. Massagué, J. 2008. TGFbeta in Cancer. Cell 134: 215-230.